Choose Your Country or Region

Trifluridine (NSC 75520)

Name: Trifluridine (NSC 75520)
Brand: Selleck Chemicals
SKU: S1778
Rating: 5 (8 reviews)

Synonyms: NSC 529182, NSC 75520, Viroptic, Trifluorothymidine, TFT

Catalog No.S1778 Purity: 99.96%

Trifluridine (NSC 529182, NSC 75520, Viroptic, Trifluorothymidine, TFT) is an anti-herpesvirus antiviral agent by interacting viral DNA replication, used primarily on the eye.

Trifluridine (NSC 75520) Chemical Structure

CAS: 70-00-8

Selleck's Trifluridine (NSC 75520) has been cited by 8 publications

Purity & Quality Control

Batch: Purity: 99.96%

99.96

Related compound libraries

Choose Selective Thymidylate Synthase Inhibitors

Biological Activity

Description

Trifluridine (NSC 529182, NSC 75520, Viroptic, Trifluorothymidine, TFT) is an anti-herpesvirus antiviral agent by interacting viral DNA replication, used primarily on the eye.

Targets

DNA synthesis ^[1]

In vitro
In vitro	Trifluridine inhibits proliferations of mouse bone marrow cells and human colorectal carcinoma cells implanted to nude mice dose-dependently. Trifluridine inhibits colony formation of bone marrow cells in a concentration-dependent manner. ^[1] Trifluridine (FTD) and 2'-deoxy-5-fluorouridine (FdUrd) are incorporated into DNA with different efficiencies due to differences in the substrate specificities of TK1 and DUT, causing abundant FTD incorporation into DNA. FTD-treated cells shows differing nuclear morphologies compared to FdUrd-treated cells. ^[2] Trifluridine inhibits proliferations of mouse bone marrow cells and human colorectal carcinoma cells implanted to nude mice dose-dependently. ^[3]

In Vivo
In vivo	Trifluridine has significantly fewer swabs positive for HSV-1 than the untreated eyes in the infected rabbits. ^[4] Trifluridine has increased antitumor activity and is incorporated into DNA more effectively than continuously infused Trifluridine in mice. Trifluridine gradually accumulates in tumor cell DNA, in a TPI-independent manner, and significantly delays tumor growth and prolonged survival in mice, compared to treatment with 5-FU derivatives. ^[5] Trifluridine results in significantly lower viral titers, fewer HSV-1-positive eyes/total during the treatment period, lower keratitis scores, fewer eyes with keratitis/total, and a shorter time to resolution of keratitis in the New Zealand rabbit ocular model. ^[6]

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2024-01-11)
NCT06039202	Not yet recruiting	Metastatic Colorectal Cancer	Holy Stone Healthcare Co. Ltd	January 2024	Phase 2
NCT05228184	Recruiting	Congenital Hypothyroidism	IBSA Institut Biochimique SA\|Cromsource	January 21 2022	Phase 4
NCT04944017	Recruiting	Parkinson''s Disease\|Depression	Yale University\|Fox (Michael J.) Foundation for Parkinson''s Research	November 23 2021	Phase 2
NCT04554836	Active not recruiting	Adenocarcinoma of the Colon\|Adenocarcinoma of the Rectum	TheraOp	December 29 2020	Phase 2
NCT04166604	Recruiting	Metastatic Colorectal Cancer	GERCOR - Multidisciplinary Oncology Cooperative Group	May 20 2020	Phase 2

References

+ Expand

Chemical lnformation & Solubility

Molecular Weight	296.2	Formula	C₁₀H₁₁F₃N₂O₅
CAS No.	70-00-8	SDF	Download Trifluridine (NSC 75520) SDF
Smiles	C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O
Storage (From the date of receipt)	3 years-20°Cpowder	Storage of Stock Solutions Aliquot the stock solutions to avoid repeated freeze-thaw cycles	1 year-80°Cin solvent
Storage (From the date of receipt)	3 years-20°Cpowder		1 month-20°Cin solvent

In vitro
Batch:

DMSO : 59 mg/mL ( (199.18 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 59 mg/mL

Ethanol : 59 mg/mL

Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.

In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
=	×	×

Dilution Calculator Molecular Weight Calculator

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):